DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Schofield DM, Templar A, Newton J, Nesbeth DN.
Promoter engineering to optimize recombinant periplasmic Fab' fragment production in Escherichia coli.
Biotechnol Prog 2016;
32 (04) 840-847
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.